Abnormal ultrasound with follow up testing (Pilot)
Acetylcholine Receptor Antibodies
Activated Partial Thromboplastin Time (APTT)
Activated Protein C Resistance Assay
Acute and Chronic Kidney Disease
Acute Lymphoblastic Leukaemia (ALL)
Alimentary Tract Pathology (GIST)
Alkaline Phosphatase (ALP) Isoenzymes
Alpha 1 Antitrypsin and Phenotype Identification
Aluminium in Water/Dialysis Fluid (Educational)
Aminoglycoside Induced deafness
Andrology: Semen Analysis (Sperm Motility, Concentration & Morphology)
Antenatal Antibody Titration (ANT)
Antibodies to Nuclear and Related Antigens
Antibody to Fungal and Related Antigens
Antithrombin Antigen and Activity Assays
B-Type Natriuretic Peptide (BNP)
BCR::ABL1 and AML Translocation Identification
BCR::ABL1 Kinase Domain Variant (Mutation) Status
BCR::ABL1 Major Quantification
BCR::ABL1 Minor Quantification
Blood Parasite Screening and Identification (Haematology)
Bone Marrow Trephine Biopsy (BMT)
BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia
BRCA and HRR gene variant classification
BRCA testing for ovarian and prostate cancer - somatic
BRCA testing for ovarian, breast, prostate and pancreatic cancer - germline
BRCA testing in prostate cancer – cfDNA (Pilot)
Breast Cancer - Tumour expression profiling (Pilot)
Breast cancer (PIK3CA testing) (Pilot)
Breast HER2 ISH (Interpretive and Technical)
Breast Pathology (Hormonal Receptors ER & PR)
C1 Esterase Inhibitor and Functional Complement Assays
Cardiac Markers (Point of Care)
Central Nervous System (CNS) Tumours
Cerebrospinal Fluid (CSF) Immunophenotyping (Pilot)
Charcot Marie Tooth disease and related sensory and motor neuropathies
Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status
Chronic Lymphocytic Leukaemia (CLL) TP53 analysis
CoaguChek XS, CoaguChek XS Plus, CoaguChek XS Pro & Pro II (PT/INR)
Colorectal cancer - Extended MMR
Colorectal cancer - mismatch repair (MMR)
Copper and Iron in Solid Martices e.g. Liver (Educational)
Covid-19 High throughput Direct RT-LAMP assay
Crossmatching by Flow Cytometry (Scheme 2B)
Cryptococcal antigen detection
CSF β2 Transferrin/Beta Trace Protein
Cystic fibrosis and CFTR-related disorders
Detection of cells coated with C3d
Detection of cells coated with IgG
Diagnostic Cytopathology Cell Block EQA Scheme
Digital Blood Film Morphology for CPD
Digital Diagnostic Ultrastructural Pathology (Pilot)
Digital Interpretative Diagnostic Cytopathology
Digital Pathology Imaging (Pilot)
Direct Immunofluorescence (DIF)
Direct Oral Anticoagulant (DOAC) Assay (Pilot)
Disorders of Sex Development (DSD)
DNA Diagnostics for Haemoglobinopathies
DNA extraction from formalin-fixed paraffin embedded (FFPE) tissue
DNA extraction from fresh frozen (FF) tissue *
DNA extraction from venous blood
DNA HLA Typing at 1st Field Resolution (Scheme 4A1)
Educational Cross Match (Scheme EDXM)
Educational Interpretive Clinical Scenarios (Scheme iED)
Educational Scheme (Scheme ED)
Embryology: Embryo Morphology, Time Lapse Annotation
Enhanced Liver Fibrosis (ELF) Score
Exome Sequencing Data Interpretation
Factor II, V, VII VIII, IX, X, XI, XII Assays
Familial Colorectal Cancer and Polyposis
Familial Endocrine tumour predisposition disorders
Familial Hypercholesterolaemia
Fibrinogen Evaluation (Clauss method)
Fragile X Syndrome and FMR1-related disorders
Frozen Section (Companion Scheme to Specialist Techniques & Neuropathology)
Haematological Malignancy Bone Marrow Aspirate Assessment (Pilot)
Head and Neck Pathology (Oral, ENT & Combined)
Heparin Dosage Assessment (HDA) by APTT
Hereditary breast and ovarian cancer disorders (HBOC)
HLA Antibody Detection (Scheme 6)
HLA Antibody Specificity Analysis (Scheme 3)
HLA Genotyping for Coeliac and other HLA associated diseases (Scheme 8)
HLA-related Pharmacogenetics (Scheme 7)
Insulin-like Growth Factor Binding Protein-3
Interferon Gamma Release Assays (Mycobacterium tuberculosis) IGRA TB
Interpretative Comments in Clinical Chemistry
Interpretative: HFE Genotype and Hereditary Haemochromatosis (Scheme 5B)
Leukaemia Diagnostic Interpretation (Part 2)
Leukaemia Immunophenotyping (Part 1)
Liquid Newborn Haemoglobinopathy Screening
Low Level Leucocyte Enumeration
Lung cancer - circulating free (cf) DNA in lung cancer *
Lupus Anticoagulant Screening/Assay
Lymphoid Gene Panels (Pilot - Not Accredited)
Maternal cell contamination (MCC) and fetal sexing
Measles and Mumps IgG serology
Measurable Residual Disease for ALL by Flow Cytometry
Measurable Residual Disease for AML by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for AML by Molecular Methods (Pilot - Not Accredited)
Measurable Residual Disease for CLL by Flow Cytometry (Pilot - Not Accredited)
Measurable Residual Disease for Lymphoid Neoplasms by Molecular Methods (Pilot - Not Accredited)
Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Pilot - Not Accredited)
Mega Block (Companion Scheme to Specialist Techniques & Neuropathology)
Microsatellite Instability (MSI)
Mismatch Repair (MMR) Proteins
Mk-4 at endogenous conecentrations in human serum
MK-7 at endogenous concentrations in human serum
Molecular detection of C. trachomatis and N. gonorrhoeae
Molecular detection of faecal parasites
Molecular detection of malaria
Molecular detection of Mycobacteria
Molecular detection of respiratory viruses
Molecular detection of SARS-CoV-2
Molecular detection of viruses in CSF
Molecular Genetics of Thrombophilia Testing (Factor V Leiden)
Molecular testing for cystic fibrosis (CF)
Molecular testing for Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
Molecular testing for Severe Combined Immunodeficiency (SCID) (Pilot)
Molecular Tissue identification
Monoclonal Protein Identification
Myelin Associated Glycoprotein IgM Antibodies (MAG)
Myeloid Gene Panels (Pilot - Not Accredited)
Myeloproliferative Neoplasms Diagnostic Testing (Partially Accredited)
Neurofibromatosis and rasopathies
Neuropathology (Cellular Pathology)
Neuropathology (Immunocytochemistry & In-Situ Hybridisation)
Next Generation Sequencing (NGS) germline *
Next Generation Sequencing (NGS) somatic - tumour testing only *
Next Generation Sequencing (NGS) somatic - tumour with germline subtraction analysis *
Non-Invasive Prenatal Testing (NIPT) for aneuploidies *
Non-Invasive Prenatal Testing (NIPT) for common microdeletions *
Non-Invasive Prenatal Testing (NIPT) for sexing *
Non-Small Cell Lung Cancer (NSCLC) ALK IHC
Non-Small Cell Lung Cancer (NSCLC) ALK ISH *Pilot*
Non-Small Cell Lung Cancer (NSCLC) PD-L1 IHC *Pilot*
Non-Small Cell Lung Cancer (NSCLC) ROS1 FISH *Pilot*
Paediatric Acute Leukaemia Translocations
Paroxysmal Nocturnal Haemoglobinuria
Parvovirus B19 and Rubella serology
Pathogenicity of germline sequence variants (Classification only)
Pathogenicity of germline postnatal copy number variants (CNV) (Pilot)
Pathogenicity of germline sequence variants (Classification & Interpretation)
Pathogenicity of haematological neoplasm variants (Pilot)
Pathogenicity of prenatal copy number variants (CNV) (Pilot)
Pathogenicity of RNA splicing variants (Pilot)
Pathogenicity of somatic sequence variants (Pilot)
PGT for blastomere FISH (Stages 1 and 2)
PGT for monogenic disorders (Stage 1)
PGT for monogenic disorders (Stage 2)
PGT for structural rearrangements
Phospholipase A2 Receptor Antibodies (PLA2R)
Placental Growth Factor (PLGF)
Point of Care C-Reactive Protein
Post-Stem Cell Transplant Chimerism Monitoring
Postnatal constitutional copy number variants (CNV) detection
Prediction of 5-Fluorouracil Toxicity (DPYD)
Prediction of Thiopurine toxicity (TPMT) (Pilot)
Pregnancy loss (Molecular methods and G-banding)
Prenatal constitutional copy number variant (CNV) detection
Primary Immunodeficiency disorders (PID)
Prostate Specific Antigen (PSA)
Protein C Antigen and Activity Assay
Protein S Total and Free Antigen Assay
Prothrombin Time (PT)/INR (Venous/Capillary methods)
Teaching programmes for blood and faecal parasitology
Thromboelastometry and Thromboelastography
Tissue inhibitor of metalloproteinase I (TIMP-I)
Training, Assessment and Competency Tool (TACT)
Transmission Electron Microscopy (TEM)
Triple Negative Breast Cancer (TNBC) PD-L1 IHC *Pilot*
Ultrasensitive C-Reactive Protein
Urinary Catecholamines & Metabolites